Australia Bispecific Antibodies Market Size & Outlook, 2025-2031
Australia Bispecific Antibodies Market Size
According to Straits Research analysis, the Australia Bispecific Antibodies Market was valued at USD 47.59 Million in 2024 and is projected to reach USD 132.04 Million by 2031, expanding at a CAGR of 16.5% during the forecast period. This growth is driven mainly by the pharmaceutical sector's unmet needs for the efficient treatment of chronic illnesses such as cancer and autoimmune diseases. Other contributing sectors include agriculture, where biotechnological applications of bispecific antibodies are employed for disease resistance in crops, and the chemical industry for targeted therapies. Emerging trends include green bioprocessing and sustainability in antibody production, along with technological advancements in genetic engineering and protein design. The remarkable growth performance stipulates Australia's strategic positioning to leverage the export potential in the global bispecific antibody market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Australia Bispecific Antibodies Market Highlights
- By segment, Bi-specific T-cell engager emerged as the largest Type in terms of market size in 2024.
- Bi-specific T-cell engager is anticipated to remain the most attractive Type segment, recording the fastest growth during the forecast period.
- In 2024, Australia represented 0.86% of the overall global bispecific antibodies market size.
- United States is projected to lead the global bispecific antibodies market size by 2031.
- Across Asia Pacific, China is anticipated to hold the dominant position in market by 2031.
- India is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 454.85 Million by 2031.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2031 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2031 |
| Market Size In 2024 | USD 47.59 Million |
| Market Size In 2031 | USD 132.04 Million |
| Largest segment | Bi-specific T-cell engager |
| Fastest segment | Bi-specific T-cell engager |
| Units | Revenue in USD Million |
| CAGR | 16.5% (2025-2031) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Australia Bispecific Antibodies Market Share By Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Type |
|
| Therapeutic Areas |
|
| Target |
|
Australia Bispecific Antibodies Market By Type 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Australia Bispecific Antibodies Market By Therapeutic Areas 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Australia Bispecific Antibodies Market By Target 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
